11 research outputs found

    Incerteza na doença e motivação para o tratamento em diabéticos tipo 2

    Get PDF
    AIMS: To characterize the uncertainty in illness and the motivation for treatment and to evaluate the existing relation between these variables in individuals with type 2 diabetes. METHOD: Descriptive, correlational study, using a sample of 62 individuals in diabetes consultation sessions. The Uncertainty Stress Scale and the Treatment Self-Regulation Questionnaire were used. RESULTS: The individuals with type 2 diabetes present low levels of uncertainty in illness and a high motivation for treatment, with a stronger intrinsic than extrinsic motivation. A negative correlation was verified between the uncertainty in the face of the prognosis and treatment and the intrinsic motivation. DISCUSSION: These individuals are already adapted, acting according to the meanings they attribute to illness. Uncertainty can function as a threat, intervening negatively in the attribution of meaning to the events related to illness and in the process of adaptation and motivation to adhere to treatment. Intrinsic motivation seems to be essential to adhere to treatment.OBJETIVOS: Caracterizar la incertidumbre ante la enfermedad y la motivación para el tratamiento y evaluar la relación existente entre estas variables en diabéticos tipo 2. MÉTODO: Estudio descriptivo, correlacional, en una muestra de 62 diabéticos atendidos en consulta. Usadas la Escala de Incertidumbre ante la Enfermedad y la Escala de Motivación para el Tratamiento. RESULTADOS: Los diabéticos tipo 2 presentan bajos niveles de incertidumbre ante la enfermedad y una elevada motivación para el tratamiento, siendo la motivación intrínseca más elevada que la extrínseca. Se verificó correlación negativa entre la incertidumbre frente al pronóstico y tratamiento y la motivación intrínseca para el tratamiento. DISCUSIÓN: Estos pacientes se encuentran adaptados actuando en conformidad con los significados que atribuyen a la enfermedad. La incertidumbre puede funcionar como amenaza interfiriendo negativamente en la atribución de significados de los acontecimientos relacionados con la enfermedad y con el proceso de adaptación y motivación para adherirse al tratamiento. La motivación intrínseca parece ser un aspecto fundamental en la motivación para el tratamiento.OBJETIVOS: Caracterizar a incerteza na doença e a motivação para o tratamento e avaliar a relação existente entre estas variáveis, em diabéticos tipo 2. MÉTODO: Estudo descritivo, correlacional, numa amostra de 62 diabéticos atendidos em consulta. Aplicadas a Escala de Incerteza na Doença e a Escala de Motivação para o Tratamento. RESULTADOS: Os diabéticos tipo 2 apresentam baixos níveis de incerteza na doença e elevada motivação para o tratamento. A motivação intrínseca é mais elevada do que a extrínseca. Existe uma correlação negativa entre a incerteza face ao prognóstico e tratamento e a motivação intrínseca para o tratamento. DISCUSSÃO: Os resultados sugerem que estes indivíduos se encontram adaptados agindo em conformidade com os significados que atribuem à doença. A incerteza pode funcionar como ameaça interferindo negativamente na atribuição de significados aos acontecimentos relacionados com a doença e com o processo de adaptação e motivação para adesão ao tratamento. A motivação intrínseca parece ser um aspecto fundamental na motivação para o tratamento

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    Illness uncertainty and treatment motivation in type 2 diabetes patients

    No full text
    AIMS: To characterize the uncertainty in illness and the motivation for treatment and to evaluate the existing relation between these variables in individuals with type 2 diabetes. METHOD: Descriptive, correlational study, using a sample of 62 individuals in diabetes consultation sessions. The Uncertainty Stress Scale and the Treatment Self-Regulation Questionnaire were used. RESULTS: The individuals with type 2 diabetes present low levels of uncertainty in illness and a high motivation for treatment, with a stronger intrinsic than extrinsic motivation. A negative correlation was verified between the uncertainty in the face of the prognosis and treatment and the intrinsic motivation. DISCUSSION: These individuals are already adapted, acting according to the meanings they attribute to illness. Uncertainty can function as a threat, intervening negatively in the attribution of meaning to the events related to illness and in the process of adaptation and motivation to adhere to treatment. Intrinsic motivation seems to be essential to adhere to treatment

    Illness uncertainty and treatment motivation in type 2 diabetes patients

    No full text
    AIMS: To characterize the uncertainty in illness and the motivation for treatment and to evaluate the existing relation between these variables in individuals with type 2 diabetes. METHOD: Descriptive, correlational study, using a sample of 62 individuals in diabetes consultation sessions. The Uncertainty Stress Scale and the Treatment Self-Regulation Questionnaire were used. RESULTS: The individuals with type 2 diabetes present low levels of uncertainty in illness and a high motivation for treatment, with a stronger intrinsic than extrinsic motivation. A negative correlation was verified between the uncertainty in the face of the prognosis and treatment and the intrinsic motivation. DISCUSSION: These individuals are already adapted, acting according to the meanings they attribute to illness. Uncertainty can function as a threat, intervening negatively in the attribution of meaning to the events related to illness and in the process of adaptation and motivation to adhere to treatment. Intrinsic motivation seems to be essential to adhere to treatment

    Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (Intensive Care Medicine, (2021), 47, 2, (160-169), 10.1007/s00134-020-06234-9)

    No full text
    The original version of this article unfortunately contained a mistake. The members of the ESICM Trials Group Collaborators were not shown in the article but only in the ESM. The full list of collaborators is shown below. The original article has been corrected
    corecore